Kazuteru Wada

Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan

Yoshiya Tanaka, Kazuteru Wada, Yoshinori Takahashi et al. · Arthritis Research & Therapy · 2019 · 46 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Novel, Potent, and Selective Phosphodiesterase-4 Inhibitors as Antiasthmatic Agents:  Synthesis and Biological Activities of a Series of 1-Pyridylnaphthalene Derivatives

Tatsuzo Ukita, Masakatsu Sugahara, Yoshihiro Terakawa et al. · Journal of Medicinal Chemistry · 1999 · 43 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

Sarilumab monotherapy or in combination with non-methotrexate disease-modifying antirheumatic drugs in active rheumatoid arthritis: A Japan phase 3 trial (HARUKA)

Hideto Kameda, Kazuteru Wada, Yoshinori Takahashi et al. · Modern Rheumatology · 2019 · 30 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Novel Phosphodiesterase 4 Inhibitor T-440 Reverses and Prevents Human Bronchial Contraction Induced by Allergen

Kazuhiko Fujii, Hirotsugu Kohrogi, Hajime Iwagoe et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 15 citations

Medicine, Pharmacology, Hypersensitivity +11

A selective type 4 phosphodiesterase inhibitor, T-440, modulates intracellular cyclic AMP level and interleukin-2 production of Jurkat cells

Osamu Kaminuma, Akio Mori, Kazuteru Wada et al. · Immunopharmacology · 1998 · 13 citations

Life Sciences, Biochemistry, Immunology +11